Most recently, it has been recognized that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent parts as classical opioid receptors, it binds into a big range of endogenous opioids. Unlike most opioid receptors, this receptor functions being a scavenger and would not activate a